56 related articles for article (PubMed ID: 8080723)
1. Effect of interferon gamma and tumour necrosis factor alpha on sensitivity to cisplatin in ovarian carcinoma cell lines.
Clark S; McGuckin MA; Hurst T; Ward BG
Cancer Immunol Immunother; 1994 Aug; 39(2):100-4. PubMed ID: 8044830
[TBL] [Abstract][Full Text] [Related]
2. HSF1 Pathway Inhibitor Clinical Candidate (CCT361814/NXP800) Developed from a Phenotypic Screen as a Potential Treatment for Refractory Ovarian Cancer and Other Malignancies.
Pasqua AE; Sharp SY; Chessum NEA; Hayes A; Pellegrino L; Tucker MJ; Miah A; Wilding B; Evans LE; Rye CS; Mok NY; Liu M; Henley AT; Gowan S; De Billy E; Te Poele R; Powers M; Eccles SA; Clarke PA; Raynaud FI; Workman P; Jones K; Cheeseman MD
J Med Chem; 2023 Apr; 66(8):5907-5936. PubMed ID: 37017629
[TBL] [Abstract][Full Text] [Related]
3. Acquired resistance to 17-allylamino-17-demethoxygeldanamycin (17-AAG, tanespimycin) in glioblastoma cells.
Gaspar N; Sharp SY; Pacey S; Jones C; Walton M; Vassal G; Eccles S; Pearson A; Workman P
Cancer Res; 2009 Mar; 69(5):1966-75. PubMed ID: 19244114
[TBL] [Abstract][Full Text] [Related]
4. High levels of the MDM2 oncogene in paediatric rhabdomyosarcoma cell lines may confer multidrug resistance.
Cocker HA; Hobbs SM; Tiffin N; Pritchard-Jones K; Pinkerton CR; Kelland LR
Br J Cancer; 2001 Nov; 85(11):1746-52. PubMed ID: 11742497
[TBL] [Abstract][Full Text] [Related]
5. Characterization and modulation of drug resistance of human paediatric rhabdomyosarcoma cell lines.
Cocker HA; Pinkerton CR; Kelland LR
Br J Cancer; 2000 Aug; 83(3):338-45. PubMed ID: 10917549
[TBL] [Abstract][Full Text] [Related]
6. Lack of a role for MRP1 in platinum drug resistance in human ovarian cancer cell lines.
Sharp SY; Smith V; Hobbs S; Kelland LR
Br J Cancer; 1998 Jul; 78(2):175-80. PubMed ID: 9683290
[TBL] [Abstract][Full Text] [Related]
7. The role of topoisomerase I inhibitor in cisplatin-resistant ovarian cancer.
Minagawa Y; Kigawa J; Itamochi H; Terakawa N
Hum Cell; 2001 Sep; 14(3):237-43. PubMed ID: 11774743
[TBL] [Abstract][Full Text] [Related]
8. Multidrug resistance in ovarian cancer.
Fojo A; Hamilton TC; Young RC; Ozols RF
Cancer; 1987 Oct; 60(8 Suppl):2075-80. PubMed ID: 3308067
[TBL] [Abstract][Full Text] [Related]
9. Effects of a new antioestrogen, idoxifene, on cisplatin- and doxorubicin-sensitive and -resistant human ovarian carcinoma cell lines.
Sharp SY; Rowlands MG; Jarman M; Kelland LR
Br J Cancer; 1994 Sep; 70(3):409-14. PubMed ID: 8080723
[TBL] [Abstract][Full Text] [Related]
10. Transport of cisplatin and bis-acetato-ammine-dichlorocyclohexylamine Platinum(IV) (JM216) in human ovarian carcinoma cell lines: identification of a plasma membrane protein associated with cisplatin resistance.
Sharp SY; Rogers PM; Kelland LR
Clin Cancer Res; 1995 Sep; 1(9):981-9. PubMed ID: 9816070
[TBL] [Abstract][Full Text] [Related]
11. Selective potentiation of platinum drug cytotoxicity in cisplatin-sensitive and -resistant human ovarian carcinoma cell lines by amphotericin B.
Sharp SY; Mistry P; Valenti MR; Bryant AP; Kelland LR
Cancer Chemother Pharmacol; 1994; 35(2):137-43. PubMed ID: 7987990
[TBL] [Abstract][Full Text] [Related]
12. Chemosensitizing effect of an antiestrogen, toremifene, on ovarian cancer.
Mäenpää J; Sipilä P; Kangas L; Karnani P; Grönroos M
Gynecol Oncol; 1992 Sep; 46(3):292-7. PubMed ID: 1388131
[TBL] [Abstract][Full Text] [Related]
13. Combined use of tamoxifen, cyclosporin A, and verapamil for modulating multidrug resistance in human hepatocellular carcinoma cell lines.
Kim JH; Chung JB; Park IS; Kim BS; Yoo NC; Choi JH; Roh JK; Kim HS; Kwon OH; Lee KS
Yonsei Med J; 1993 Mar; 34(1):35-44. PubMed ID: 8397460
[TBL] [Abstract][Full Text] [Related]
14. Reduced drug accumulation as a major mechanism of acquired resistance to cisplatin in a human ovarian carcinoma cell line: circumvention studies using novel platinum (II) and (IV) ammine/amine complexes.
Loh SY; Mistry P; Kelland LR; Abel G; Harrap KR
Br J Cancer; 1992 Dec; 66(6):1109-15. PubMed ID: 1457352
[TBL] [Abstract][Full Text] [Related]
15. Tamoxifen modulation of cisplatin sensitivity in human malignant melanoma cells.
McClay EF; Albright KD; Jones JA; Christen RD; Howell SB
Cancer Res; 1993 Apr; 53(7):1571-6. PubMed ID: 8453625
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
